The tweet was deleted by the author.
But we saved everything 🙂.
McKesson says it works behind the scenes every day to keep medicines moving and support providers. The company states it is committed to strengthening access across communities.
McKesson says powering care locally is part of how it makes healthcare happen. Details are available at the link provided in its social media update.
MCK is trading at $769.70, which is above the MA-20 ($751.00) but below both the MA-50 ($805.82) and MA-200 ($820.16). This positioning suggests short-term upward momentum but ongoing medium- and long-term pressure from sellers. The Ichimoku Kijun on D1 is at $772.95, acting as immediate resistance just above the current price. Near-term support is found at the MA-20 ($751.00), with key support at the MA-200 ($820.16). Near-term resistance is provided by the Ichimoku Kijun ($772.95), while the MA-50 at $805.82 stands as key resistance.
Momentum signals are conflicted: the D1 MACD points to a strong sell and D1 ADX also confirms a bearish bias, yet RSI remains neutral at 51.93. Short-term oscillators (Stoch RSI and CCI) indicate overbought conditions, and BBP shows buyers are still dominant intraday, though signals are mixed across timeframes. Weekly, MCK has fallen $5.96 (0.76%) from last week’s close at $775.66, with the price now in the upper part of the weekly range. Weekly volatility stands at 7.14%. The tone remains consolidation near recent highs, but momentum indicators point toward a possible loss of bullish strength.
For the upcoming week, the expected trading range is $740 to $780, using recent volatility and current price action as a guide. Compared to the 52-week low of $637.00 and high of $999.00, the forecasted range keeps MCK in the upper third of its yearly spectrum. Based on weekly signals (RSI W1, ADX W1, MACD W1, and MA-50 W1), the probability of price increase is very low (less than 20%), making further declines more likely. The baseline scenario sees MCK fluctuating sideways within the corridor. A bullish breakout would require a sustained move above $773–$780, while a bearish outcome sees the price breaking below $751 and testing the $740–$750 support area.
Previously it was reported that McKesson was experiencing cautious market sentiment, with analysts highlighting ongoing downside risks despite short-term upward moves. In light of the latest developments, traders should remain vigilant for signs of a sustained trend reversal as the price action continues to reflect a delicate balance between support and resistance.